Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 18, 2012, Pages

  Larson, Jennifer D ^a   Thurman, Joshua M ^a   Rubtsov, Anatoly V ^a,b   Claypool, David ^a   Marrack, Philippa ^a,b   Van Dyk, Linda F ^a   Torres, Raul M ^a   Pelanda, Roberta ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Antibody; Mouse gammaherpesvirus

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; EPSTEIN BARR VIRUS; FEMALE; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS 68; HERPES VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOMODULATION; KIDNEY FUNCTION; LATENT VIRUS INFECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOID CELL; MALE; MOUSE; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; T LYMPHOCYTE; WILD TYPE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; DENDRITIC CELLS; FEMALE; HERPESVIRIDAE INFECTIONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MODELS, IMMUNOLOGICAL; RHADINOVIRUS; TUMOR VIRUS INFECTIONS;

HUMAN HERPESVIRUS 4; MAMMALIA; MURINAE; MUS; RODENTIA; VERTEBRATA;

EID: 84860821139     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203019109     Document Type: Article

References (76)

1. James JA, Harley JB, Scofield RH (2006) Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 18:462-467. (Pubitemid 44200328)
2. Posnett DN, Yarilin D (2005) Amplification of autoimmune disease by infection. Arthritis Res Ther 7:74-84. (Pubitemid 40439442)
3. Lünemann JD, Münz C (2007) Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 7:253-258.
4. Peters AL, Stunz LL, Meyerholz DK, Mohan C, Bishop GA (2010) Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol 185:4053-4062.
5. Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R (2005) Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J Virol 79:7355-7362. (Pubitemid 40756771)
6. Wang H, et al. (2006) EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 177:2793-2802. (Pubitemid 44277794)
7. Blackman MA, Flaño E, Usherwood E, Woodland DL (2000) Murine gamma-herpesvirus- 68: A mouse model for infectious mononucleosis? Mol Med Today 6:488-490.
8. Virgin HW, Speck SH (1999) Unraveling immunity to gamma-herpesviruses: A new model for understanding the role of immunity in chronic virus infection. Curr Opin Immunol 11:371-379.
9. Barton E, Mandal P, Speck SH (2011) Pathogenesis and host control of gammaherpesviruses: Lessons from the mouse. Annu Rev Immunol 29:351-397.
10. Sarawar SR, et al. (1996) Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol 70:3264-3268. (Pubitemid 26121947)
11. Stevenson PG, Doherty PC (1998) Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol 72:943-949. (Pubitemid 28116871)
12. Sangster MY, et al. (2000) Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol 164:1820-1828. (Pubitemid 30108735)
13. Flaño E, Woodland DL, Blackman MA (2002a) A mouse model for infectious mononucleosis. Immunol Res 25:201-217. (Pubitemid 34454712)
14. Stevenson PG, Cardin RD, Christensen JP, Doherty PC (1999) Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol 80:477-483. (Pubitemid 29095210)
15. Ehtisham S, Sunil-Chandra NP, NashAA (1993) Pathogenesis ofmurine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol 67:5247-5252. (Pubitemid 23241355)
16. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T (1998) Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 187:1941-1951. (Pubitemid 28285564)
17. Weck KE, Kim SS, Virgin HW IV, Speck SH (1999b) B cells regulate murine gammaherpesvirus 68 latency. J Virol 73:4651-4661. (Pubitemid 29246723)
18. Weck KE, Kim SS, Virgin HW IV, Speck SH (1999a) Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J Virol 73: 3273-3283. (Pubitemid 29135720)
19. Flaño E, Kim IJ, Woodland DL, Blackman MA (2002b) Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196:1363-1372. (Pubitemid 35375555)
20. Flaño E, Kayhan B, Woodland DL, Blackman MA (2005) Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation. J Immunol 175:3225-3234. (Pubitemid 41170543)
21. Hochreiter R, Ptaschinski C, Kunkel SL, Rochford R (2007) Murine gammaherpesvirus- 68 productively infects immature dendritic cells and blocks maturation. J Gen Virol 88: 1896-1905. (Pubitemid 47009930)
22. Cardin RD, Brooks JW, Sarawar SR, Doherty PC (1996) Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med 184:863-871.
23. Brooks JW, et al. (1999) Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol 73:9650-9654. (Pubitemid 29487125)
24. Sparks-Thissen RL, Braaten DC, Kreher S, Speck SH, Virgin HW, 4th (2004) An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J Virol 78:6827-6835. (Pubitemid 38781520)
25. Braaten DC, Sparks-Thissen RL, Kreher S, Speck SH, Virgin HW, 4th (2005) An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection. J Virol 79:2573-2583. (Pubitemid 40204611)
26. Sparks-Thissen RL, et al. (2005) CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma. Virology 338:201-208. (Pubitemid 41019189)
27. Barton ES, Lutzke ML, Rochford R, Virgin HW, 4th (2005) Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J Virol 79:14149-14160. (Pubitemid 41552713)
28. Gargano LM, Forrest JC, Speck SH (2009) Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo. J Virol 83:1474-1482.
29. Smith KA, Efstathiou S, Cooke A (2007) Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J Immunol 179: 7325-7333.
30. Yarilin DA, Valiando J, Posnett DN (2004) A mouse herpesvirus induces relapse of experimental autoimmune arthritis by infection of the inflammatory target tissue. J Immunol 173:5238-5246. (Pubitemid 39387807)
31. Peacock JW, Elsawa SF, Petty CC, Hickey WF, Bost KL (2003) Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. Eur J Immunol 33:1849-1858. (Pubitemid 37120856)
32. Speck SH, Virgin HW (1999) Host and viral genetics of chronic infection: A mouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol 2:403-409. (Pubitemid 29366963)
33. Pelanda R, Torres RM (2006) Receptor editing for better or for worse. Curr Opin Immunol 18:184-190. (Pubitemid 43327300)
34. Goodnow CC (2007) Multistep pathogenesis of autoimmune disease. Cell 130:25-35.
35. Shlomchik MJ (2008) Sites and stages of autoreactive B cell activation and regulation. Immunity 28:18-28.
36. Sekiguchi DR, et al. (2006) Development and selection of edited B cells in B6.56R mice. J Immunol 176:6879-6887. (Pubitemid 43787869)
37. Nguyen C, Limaye N, Wakeland EK (2002) Susceptibility genes in the pathogenesis of murine lupus. Arthritis Res 4(suppl 3):S255-S263.
38. Fairhurst AM, Wandstrat AE, Wakeland EK (2006) Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv Immunol 92: 1-69. (Pubitemid 44828118)
39. Xu Z, Morel L (2010) Genetics of systemic lupus erythematosus: Contributions of mouse models in the era of human genome-wide association studies. Discov Med 10: 71-78.
40. Morel L, et al. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 97: 6670-6675. (Pubitemid 30412772)
41. van Dyk LF, Virgin HW, 4th, Speck SH (2003) Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol 77:5118-5126.
42. Hu X, Ivashkiv LB (2009) Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 31:539-550.
43. Nicoletti F, et al. (2000) Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice. Eur J Immunol 30: 438-447. (Pubitemid 30098836)
44. Sobel ES, Satoh M, Chen Y, Wakeland EK, Morel L (2002) The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells. J Immunol 169:2694-2700. (Pubitemid 34921018)
45. + B-cell population is important for the development of autoimmunity. Blood 118:1305-1315.
46. Hao Y, O'Neill PJ, Naradikian MS, Scholz JL, Cancro MP (2011) A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118:1294-1304.
47. Lardans V, et al. (1996) Polyclonal B lymphocyte activation induced by mouse hepatitis virus A59 infection. J Gen Virol 77:1005-1009. (Pubitemid 26142335)
48. Hunziker L, et al. (2003) Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol 4:343-349. (Pubitemid 36432316)
49. Kaplan ME, Tan EM (1968) Antinuclear antibodies in infectious mononucleosis. Lancet 1:561-563.
50. Sutton RN, Emond RT, Thomas DB, Doniach D (1974) The occurrence of auto-antibodies in infectious mononucleosis. Clin Exp Immunol 17:427-436.
51. McCombe PA, Greer JM, Mackay IR (2009) Sexual dimorphism in autoimmune disease. Curr Mol Med 9:1058-1079.
52. Rubtsov AV, Rubtsova K, Kappler JW, Marrack P (2010) Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 9:494-498.
53. Dutia BM, Clarke CJ, Allen DJ, Nash AA (1997) Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol 71:4278-4283. (Pubitemid 27204114)
54. Christensen SR, et al. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417-428. (Pubitemid 44354217)
55. Pisitkun P, et al. (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669-1672. (Pubitemid 43902669)
56. Deane JA, et al. (2007) Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27:801-810. (Pubitemid 350102256)
57. Nickerson KM, et al. (2010) TLR9 regulates TLR7- and MyD88-dependent auto-antibody production and disease in a murine model of lupus. J Immunol 184:1840-1848.
58. van Gent M, et al. (2011) EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J Immunol 186:1694-1702.
59. Buisson M, et al. (2009) A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities. J Mol Biol 391:717-728.
60. Covarrubias S, Richner JM, Clyde K, Lee YJ, Glaunsinger BA (2009) Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J Virol 83:9554-9566.
61. Guggemoos S, et al. (2008) TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J Immunol 180:438-443.
62. Santiago-Raber ML, et al. (2010) Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun 34:339-348.
63. Flaño E, Husain SM, Sample JT, Woodland DL, Blackman MA (2000) Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 165:1074-1081. (Pubitemid 30484779)
64. Liang Z, Chang S, Youn MS, Mohan C (2009) Molecular hallmarks of anti-chromatin antibodies associated with the lupus susceptibility locus, Sle1. Mol Immunol 46: 2671-2681.
65. Boname JM, de Lima BD, Lehner PJ, Stevenson PG (2004) Viral degradation of the MHC class I peptide loading complex. Immunity 20:305-317. (Pubitemid 38388232)
66. Pires de Miranda M, et al. (2008) The Gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PLoS One 3: e1654.
67. Rodrigues L, et al. (2009) Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J 28: 1283-1295.
68. Zhu J, et al. (2005) T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 115:1869-1878. (Pubitemid 40979726)
69. Wan S, Xia C, Morel L (2007) IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol 178:271-279. (Pubitemid 46033610)
70. Wan S, Zhou Z, Duan B, Morel L (2008) Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum 58:1741-1750. (Pubitemid 351847528)
71. Weslow-Schmidt JL, et al. (2007) Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J Virol 81:9778-9789. (Pubitemid 350067682)
72. Virgin HW, Wherry EJ, Ahmed R (2009) Redefining chronic viral infection. Cell 138: 30-50.
73. Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513-521.
74. Lindqvist AK, et al. (2000) A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 14:169-178.
75. Virgin HW, 4th, et al. (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894-5904.
76. Gorden KB, et al. (2005) Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 174:1259-1268.